Magali Volteau
Les Ulis, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 02, 2023
Phase 2 randomized study of abobotulinumtoxinA in patients with provoked vestibulodynia: dose-finding results.
Journal: The journal of sexual medicine
Published: October 05, 2023
A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 12, 2023
Goal Attainment after Treatment with Abobotulinumtoxina and a Tailored Home Therapy Programme in Children with Upper Limb Spasticity: Descriptive, Exploratory Analysis of a Large Randomized, Controlled Study
Journal: Journal of rehabilitation medicine
Published: October 28, 2022
Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment.
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Published: October 07, 2022
AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2).
Journal: Neurourology and urodynamics
Published: August 25, 2022
Pain Reduction With AbobotulinumtoxinA for the Treatment of Hallux Valgus in Adult Participants: Results of a Randomized and Placebo-Controlled Phase 2 Trial.
Journal: The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons
Published: January 28, 2022
Exploring the Relationship Between Clinical Presentation in Hallux Valgus and Response to AbobotulinumtoxinA Treatment.
Journal: The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons
Published: January 28, 2022
Long-term Efficacy and Safety of Liquid AbobotulinumtoxinA Formulation for Moderate-to-Severe Glabellar Lines: A Phase III, Double-Blind, Randomized, Placebo-Controlled and Open-Label Study.
Journal: Aesthetic surgery journal
Published: September 02, 2021
Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.
Journal: Aesthetic surgery journal
Published: March 19, 2021
Response to "Facial Line Outcomes (FLO-11) and Facial Line Satisfaction Questionnaire (FLSQ) Meet FDA PRO Guidance".
Journal: Aesthetic surgery journal
Published: September 22, 2020
Last Updated: 09/26/2026